| 15/05/23 | 07:00:04 | 15 May 2023 | | Mevalone authorisation in New Zealand | RNS |
| 12/05/23 | 07:00:03 | 12 May 2023 | | Regulatory approvals in California and Florida | RNS |
| 05/05/23 | 07:00:03 | 5 May 2023 | | Preliminary results for the year ended 31 Dec 2022 | RNS |
| 17/04/23 | 07:00:05 | 17 Apr 2023 | | Regulatory authorisation for Mevalone in Poland | RNS |
| 23/03/23 | 07:00:04 | 23 Mar 2023 | | US State Regulatory Approvals Update | RNS |
| 30/01/23 | 07:00:03 | 30 Jan 2023 | | First Mevalone authorisation for domestic use | RNS |
| 10/01/23 | 07:00:02 | 10 Jan 2023 | | Trading Update | RNS |
| 15/12/22 | 07:00:02 | 15 Dec 2022 | | Distribution Agreement for Mevalone in France | RNS |
| 30/11/22 | 07:00:02 | 30 Nov 2022 | | Organic Certification in Greece | RNS |
| 24/10/22 | 12:00:01 | 24 Oct 2022 | | AIM Rule 17 Notification | RNS |
| 03/10/22 | 16:39:19 | 3 Oct 2022 | | Holding(s) in Company | RNS |
| 30/09/22 | 07:00:12 | 30 Sept 2022 | | Eden Half Yearly Report | RNS |
| 28/09/22 | 08:46:39 | 28 Sept 2022 | | Appointment of Auditor | RNS |
| 26/09/22 | 07:00:10 | 26 Sept 2022 | | Eden granted US EPA regulatory approval | RNS |
| 02/09/22 | 07:00:08 | 2 Sept 2022 | | Appointment of Non-Executive Director | RNS |
| 22/08/22 | 07:00:04 | 22 Aug 2022 | | Trading Update | RNS |
| 07/07/22 | 07:00:08 | 7 Jul 2022 | | Exercise of Options | RNS |
| 29/06/22 | 12:18:10 | 29 Jun 2022 | | Result of AGM | RNS |
| 29/06/22 | 07:00:06 | 29 Jun 2022 | | AGM Statement | RNS |
| 08/06/22 | 07:12:24 | 8 Jun 2022 | | Notice of AGM & Publication of Annual Report | RNS |
| 07/06/22 | 07:00:05 | 7 Jun 2022 | | Investor Meet Company: 2021 Results Presentation | RNS |
| 31/05/22 | 10:29:34 | 31 May 2022 | | Director/PDMR Shareholding | RNS |
| 31/05/22 | 07:00:05 | 31 May 2022 | | Preliminary results | RNS |
| 16/05/22 | 17:05:43 | 16 May 2022 | | Holding(s) in Company | RNS |
| 10/05/22 | 07:00:02 | 10 May 2022 | | Regulatory update | RNS |
| 02/03/22 | 07:00:07 | 2 Mar 2022 | | Trading Update | RNS |
| 02/12/21 | 07:00:06 | 2 Dec 2021 | | New Major Crop Use for Mevalone in France | RNS |
| 20/10/21 | 07:00:07 | 20 Oct 2021 | | Admission to the US OTC Market | RNS |
| 28/09/21 | 07:00:02 | 28 Sept 2021 | | Half Yearly Report | RNS |
| 24/09/21 | 12:32:11 | 24 Sept 2021 | | Notice of General Meeting | RNS |
| 01/09/21 | 07:00:10 | 1 Sept 2021 | | Issuing of Annual Report & Notice of GM | RNS |
| 26/08/21 | 07:00:02 | 26 Aug 2021 | | New label extension for biofungicide in Portugal | RNS |
| 28/07/21 | 14:53:35 | 28 Jul 2021 | | Director/PDMR Shareholding | RNS |
| 27/07/21 | 07:00:05 | 27 Jul 2021 | | Agreement with Sipcam in North Africa | RNS |
| 23/07/21 | 07:00:09 | 23 Jul 2021 | | Grant of Awards under Long-Term Incentive Plan | RNS |
| 12/07/21 | 16:10:55 | 12 Jul 2021 | | Holding(s) in Company | RNS |
| 05/07/21 | 07:00:07 | 5 Jul 2021 | | Regulatory approvals | RNS |
| 01/07/21 | 12:19:47 | 1 Jul 2021 | | Publication of Report and Accounts | RNS |
| 30/06/21 | 12:03:34 | 30 Jun 2021 | | Result of AGM | RNS |
| 30/06/21 | 07:00:06 | 30 Jun 2021 | | Preliminary Results for Year Ended 31 Dec 2020 | RNS |
| 29/06/21 | 11:27:52 | 29 Jun 2021 | | Virtual Investor Conference – Link for webinar | RNS |
| 07/06/21 | 15:28:25 | 7 Jun 2021 | | Notice of AGM, investor conference & Accounts | RNS |
| 12/05/21 | 07:00:03 | 12 May 2021 | | Milestone Agreement signed with Corteva | RNS |
| 10/05/21 | 07:00:07 | 10 May 2021 | | Regulatory approval for Cedroz™ in Italy | RNS |
| 01/04/21 | 07:00:09 | 1 Apr 2021 | | Grant of Awards under Long-Term Incentive Plan | RNS |
| 31/03/21 | 07:00:04 | 31 Mar 2021 | | New authorisations for bio-fungicide in Spain | RNS |
| 29/03/21 | 13:27:10 | 29 Mar 2021 | | Holding(s) in Company | RNS |
| 19/02/21 | 16:41:14 | 19 Feb 2021 | | Second Price Monitoring Extn | RNS |
| 19/02/21 | 16:35:45 | 19 Feb 2021 | | Price Monitoring Extension | RNS |
| 19/02/21 | 14:05:56 | 19 Feb 2021 | | Second Price Monitoring Extn | RNS |
